Studies on the biology, chemotherapy and distribution of warble fly in Pakistan

Khan, M.Q.; Irshad, Hamid; Jahangir, Muhammad; Razzaq, Abdul

doi:10.20506/rst.31.3.2177

Cited by 3 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the product information, the manufacturer's dose recommendation for cattle and sheep is 0.2 mg/kg doramectin for intramuscular administration (accessed March 2021). This dose has also been administered to goats in some pharmacokinetic, milk kinetic, and efficacy studies with a subcutaneous route of administration (28)(29)(30)(31)(32)(33). In the current case, 0.3 mg/kg doramectin were administered subcutaneously.…”

Section: Discussionmentioning

confidence: 99%

First Sequencing of Caprine Mdr1 (Abcb1) mRNA Due to Suspected Neurological Adverse Drug Reaction in a Thuringian Goat Following Extra-Label Use of Doramectin

et al. 2021

View full text Add to dashboard Cite

The multidrug resistance gene MDR1 encodes for an efflux transporter called P-glycoprotein (P-gp). In the canine Mdr1 gene, a nonsense mutation was identified in certain dog breeds causing increased drug sensitivity to various P-gp substrates such as antiparasitic macrocyclic lactones. Symptoms of neurologic toxicity include ataxia, depression, salivation, tremor, apparent blindness, and mydriasis. In the current report, a Thuringian goat developed similar neurological signs after treatment with doramectin, a compound from the macrocyclic lactone class. Therefore, Mdr1 might be defective in this individual goat. For diagnostic purposes, sequencing of the complete mRNA transcript coding for caprine Mdr1 was performed to investigate a potential missense mutation. The Mdr1 transcripts of two related goats without drug sensitivity were also sequenced to allow differential diagnosis and were compared to the suspected drug-sensitive goat. The only position where the Mdr1 sequence from the suspected drug-sensitive goat differed was in the 3′-untranslated region, being a heterozygous single nucleotide polymorphism c.3875C>A. It can be suspected that this variant affects the expression level, stability, or translation efficiency of the Mdr1 mRNA transcript and therefore might be associated with the suspected drug sensitivity. To clarify this, further studies are needed, particularly investigating the Mdr1 mRNA and protein expression levels from brain material of affected goats. In conclusion, Mdr1 variants may exist not only in dogs, but also in individual goats. The current report provides the first Mdr1 mRNA transcript sequence of a goat and therefore represents the basis for more detailed Mdr1 sequence and expression analyses.

show abstract

Section: Discussionmentioning

confidence: 99%

First Sequencing of Caprine Mdr1 (Abcb1) mRNA Due to Suspected Neurological Adverse Drug Reaction in a Thuringian Goat Following Extra-Label Use of Doramectin

et al. 2021

View full text Add to dashboard Cite

show abstract

Myiasis of domestic and wild ruminants caused by Hypodermatinae in the Mediterranean and Indian subcontinent

Yadav

Fontán

Katoch

et al. 2017

Veterinary Parasitology

View full text Add to dashboard Cite

Treatment and control of bovine hypodermosis with ivermectin long-acting injection (IVOMEC® GOLD)

Otranto

Johnson

Syvrud³

et al. 2016

Parasites Vectors

View full text Add to dashboard Cite

BackgroundThe studies reported here were conducted to assess the efficacy of ivermectin long-acting injection (IVM LAI; IVOMEC® GOLD, Merial; 3.15 % w/v ivermectin) for the treatment and control of natural infestations of cattle by Hypoderma bovis and Hypoderma lineatum, which are the most economically important oestrid flies of cattle in the northern hemisphere.MethodsCattle selected from herds with a history of Hypoderma infestation were grouped into blocks of three (Italy, 33 cattle; Germany, 30 cattle) or two (USA, 16 cattle) animals each, on the basis of positivity at the pre-treatment anti-Hypoderma antibody titres. Within each block, animals were randomly allocated to one of the following treatment regimens: saline (control); IVM LAI, administered at the predicted time of occurrence of first-instar larvae (Italy, Germany, USA); IVM LAI, administered at the predicted time of occurrence of second- and/or third-instar larvae (Italy, Germany). All treatments were administered by subcutaneous injection in correspondence of the area anterior to the shoulder at 1 ml/50 kg body weight, which corresponds to 630 mcg IVM/kg for IVM LAI.ResultsNo Hypoderma larvae emerged from animals treated with IVM LAI, whereas live H. lineatum (Italy) or H. bovis (Germany, USA) larvae were collected from saline-treated animals (P < 0.01). No adverse reactions to treatments were in any of the animals enrolled in the study.ConclusionsThe results from this study demonstrate that ivermectin in a long-acting formulation is 100 % efficacious in the treatment of cattle naturally infested by H. bovis and H. lineatum larvae at all stages of development. IVM LAI can, therefore, be used as ‘prophylactic’ treatment for Hypoderma spp. infestations in absence of external evidence of their presence and thus prior to skin and carcass damage, and as ‘therapeutic’ treatment, when warbles are already present.

show abstract

Studies on the biology, chemotherapy and distribution of warble fly in Pakistan

Cited by 3 publications

References 9 publications

First Sequencing of Caprine Mdr1 (Abcb1) mRNA Due to Suspected Neurological Adverse Drug Reaction in a Thuringian Goat Following Extra-Label Use of Doramectin

First Sequencing of Caprine Mdr1 (Abcb1) mRNA Due to Suspected Neurological Adverse Drug Reaction in a Thuringian Goat Following Extra-Label Use of Doramectin

Myiasis of domestic and wild ruminants caused by Hypodermatinae in the Mediterranean and Indian subcontinent

Treatment and control of bovine hypodermosis with ivermectin long-acting injection (IVOMEC® GOLD)

Contact Info

Product

Resources

About